Rochester, NY - Researchers are calling for beta-blocker treatment for patients with intermittent claudication, arguing that it is "old school" to avoid them in this high-risk group [1]. The new study ...
Paclitaxel-coated balloons and paclitaxel-eluting stents should be withheld from routine use in patients with intermittent claudication until further evidence on their safety profile is available, an ...
Drug-coated devices not associated with improved outcomes in patients with peripheral artery disease
Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in peripheral artery disease (PAD), ...
Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in peripheral artery disease (PAD), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results